Sutton Wealth Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-271
Closed -$31.3K 1247
2022
Q4
$31.3K Buy
271
+2
+0.7% +$233 0.01% 538
2022
Q3
$29.1K Buy
269
+36
+15% +$5.16K 0.01% 534
2022
Q2
$42.1K Buy
233
+2
+0.9% +$358 0.02% 427
2022
Q1
$39.5K Sell
231
-3
-1% -$566 0.01% 483
2021
Q4
$49K Buy
234
+3
+1% +$620 0.02% 423
2021
Q3
$44.5K Hold
231
0.02% 425
2021
Q2
$65.4K Hold
231
0.02% 339
2021
Q1
$48.9K Hold
231
0.02% 399
2020
Q4
$45.4K Hold
231
0.02% 383
2020
Q3
$38K Hold
231
0.02% 361
2020
Q2
$32.1K Hold
231
0.02% 412
2020
Q1
$14.4K Hold
231
0.01% 555
2019
Q4
$25.3K Hold
231
0.01% 510
2019
Q3
$23.9K Hold
231
0.01% 519
2019
Q2
$29.6K Hold
231
0.02% 458
2019
Q1
$29.5K Hold
231
0.02% 449
2018
Q4
$28.9K Hold
231
0.02% 411
2018
Q3
$51.2K Hold
231
0.03% 287
2018
Q2
$37K Hold
231
0.03% 373
2018
Q1
$21.6K Hold
231
0.02% 541
2017
Q4
$16.1K Hold
231
0.01% 629
2017
Q3
$13.7K Buy
231
+107
+86% +$5.32K 0.01% 670
2017
Q2
$5.14K Hold
124
﹤0.01% 869
2017
Q1
$5.5K Hold
124
﹤0.01% 831
2016
Q4
$5.16K Hold
124
﹤0.01% 843
2016
Q3
$4.69K Hold
124
﹤0.01% 828
2016
Q2
$4.13K Hold
124
﹤0.01% 824
2016
Q1
$3.74K Buy
+124
New +$3.62K ﹤0.01% 818

Other funds holding MED

Sutton Wealth Advisors's MED Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Medifast (MED) in Q1 2023, closing a stake of 271 shares — an estimated $31.3K sold.

Sutton Wealth Advisors first reported a position in MED in Q1 2016 and held it in 28 quarters. The position peaked at $65.4K in Q2 2021. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 271 Medifast shares in Q1 2023, an estimated $31.3K.
  • Sutton Wealth Advisors first reported a position in Medifast in Q1 2016 and held it in 28 quarters.
  • Sutton Wealth Advisors's Medifast position peaked at $65.4K in Q2 2021.
  • 267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.